Evidence map›Paper›PMID 37025794›Full record

ArticleHeliyon2023

A novel method for diagnosing Alzheimer's disease using deep pyramid CNN based on EEG signals.

Wei Xia, Ran Zhang, Xiao Zhang, Muhammad Usman

Abstract read
In one paragraph

Article in Heliyon, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Wei XiaSchool of Medical Informatics and Engineering, Xuzhou Medical University, Xuzhou 221000, China.
Ran ZhangSchool of Medical Informatics and Engineering, Xuzhou Medical University, Xuzhou 221000, China.
Xiao ZhangSchool of Medical Informatics and Engineering, Xuzhou Medical University, Xuzhou 221000, China.
Muhammad UsmanSchool of Medical Informatics and Engineering, Xuzhou Medical University, Xuzhou 221000, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: The diagnosis of Alzheimer's disease (AD) using electroencephalography (EEG) has garnered more attention recently. New methods: In this paper, we present a novel approach for the diagnosis of AD, in terms of classifying the resting-state EEG of AD, mild cognitive impairment (MCI), and healthy control (HC). To overcome the hurdles of limited data available and the over-fitting problem of the deep learning models, we studied overlapping sliding windows to augment the one-dimensional EEG data of 100 subjects (including 49 AD subjects, 37 MCI subjects and 14 HC subjects). After constructing the appropriate dataset, the modified DPCNN was used to classify the augmented EEG. Furthermore, the model performance was evaluated by 5 times of 5-fold cross-validation and the confusion matrix has been obtained. Results: The average accuracy rate of the model for classifying AD, MCI, and HC is 97.10%, and the F1 score of the three-class classification model is 97.11%, which further proves the model's excellent performance. Conclusions: Therefore, the DPCNN proposed in this paper can accurately classify the one-dimensional EEG of AD and is worthy of reference for the diagnosis of the disease.

Indexed as

Alzheimer's diseaseDeep learningDeep pyramid convolutional neural networkElectroencephalographyMild cognitive impairment

Identifiers

PMID37025794
PMCPMC10070085

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.